Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer

Carcinogenesis

Volumn 33, Issue 7, 2012, Pages 1384-1390

  Li, Donghui ^a   Duell, Eric J ^b   Yu, Kai ^c   Risch, Harvey A ^d   Olson, Sara H ^e   Kooperberg, Charles ^f   Wolpin, Brian M ^g,h   Jiao, Li ⁱ   Dong, Xiaoqun ^a   Wheeler, Bill ^j   Arslan, Alan A ^k,l   Bueno de Mesquita, H Bas ^m,n   Fuchs, Charles S ^g,h   Gallinger, Steven ^o   Gross, Myron ^p   Hartge, Patricia ^c   Hoover, Robert N ^c   Holly, Elizabeth A ^q   Jacobs, Eric J ^r   Klein, Alison P ^s,t   LaCroix, Andrea ^f   Mandelson, Margaret T ^f,u   Petersen, Gloria ^v   Zheng, Wei ^w   Agalliu, Ilir ^x   Albanes, Demetrius ^c   Boutron Ruault, Marie Christine ^y   Bracci, Paige M ^q   Buring, Julie E ^h,z   Canzian, Federico ^aa   Chang, Kenneth ^ab   Chanock, Stephen J ^c,ac   Cotterchio, Michelle ^ad,ae   Gaziano, J Michael ^h,af   Giovannucci, Edward L ^h,ag   Goggins, Michael ^s   Hallmans, Göran ^ah   Hankinson, Susan E ^h,ag   Hoffman Bolton, Judith A ^t   Hunter, David J ^h,ag   Hutchinson, Amy ^c,ac   Jacobs, Kevin B ^ac,ai   Jenab, Mazda ^aj   Khaw, Kay Tee ^ak   Kraft, Peter ^h,ag   Krogh, Vittorio ^al   Kurtz, Robert C ^e   Robert R McWilliams, ^v   Mendelsohn, Julie B ^c   Patel, Alpa V ^r   Rabe, Kari G ^v   Riboli, Elio ^am   Shu, Xiao Ou ^w   Tjonneland A ^an   Tobias, Geoffrey S ^c   Trichopoulos, Dimitrios ^ag,ao   Virtamo, Jarmo ^ap   Visvanathan, Kala ^s   Watters, Joanne ^c   Yu, Herbert ^d   Zeleniuch Jacquotte, Anne ^k,l   Amundadottir, Laufey ^c   Stolzenberg Solomon, Rachael Z ^c   more..

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^c NATIONAL CANCER INSTITUTE   (United States)

^d YALE UNIVERSITY   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f Fred Hutchinson Cancer Research Center   (United States)

^g DANA FARBER CANCER INSTITUTE   (United States)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ BAYLOR COLLEGE OF MEDICINE   (United States)

^j INFORMATION MANAGEMENT SERVICES INC   (United States)

^k NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l NEW YORK UNIVERSITY   (United States)

^m NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

ⁿ UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^o MOUNT SINAI HOSPITAL   (Canada)

^p UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^q UNIVERSITY OF CALIFORNIA   (United States)

^r AMERICAN CANCER SOCIETY   (United States)

^s JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^t JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^u CENTER FOR HEALTH STUDIES   (United States)

^v MAYO CLINIC   (United States)

^w VANDERBILT INGRAM CANCER CENTER   (United States)

^x ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^y INSERM   (France)

^z HARVARD MEDICAL SCHOOL   (United States)

^aa GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^ab UNIVERSITY OF CALIFORNIA   (United States)

^ac SAIC FREDERICK INC   (United States)

^ad UNIVERSITY OF TORONTO   (Canada)

^ae CANCER CARE ONTARIO   (Canada)

^af Veterans Affairs Boston Healthcare System ^*  (United States)

^ag HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^ah UMEÅ UNIVERSITY   (Sweden)

^ai Bioinformed Consulting Services   (United States)

^aj INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^ak UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^al NATIONAL CANCER INSTITUTE   (Italy)

^am IMPERIAL COLLEGE LONDON   (United Kingdom)

^an INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^ao BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^ap NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LIVER RECEPTOR HOMOLOG 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 8; NOTCH RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR PDX 1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT PROTEIN;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CYCLE; CONTROLLED STUDY; DNA REPAIR; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; PANCREAS CANCER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TH1 CELL; TH2 CELL;

CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; PANCREATIC NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84865187562     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs151     Document Type: Article

References (50)

1. Amundadottir,L. et al. (2009) Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat. Genet., 41, 986-990.
2. Petersen,G.M. et al. (2010) A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p.15.33. Nat. Genet., 42, 224-228.
3. WTCCC. (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature, 447, 661-678.
4. Wang,K. et al. (2010) Analysing biological pathways in genome-wide association studies. Nat. Rev. Genet., 11, 843-854.
5. Cantor,R.M. et al. (2010) Prioritizing GWAS results: a review of statistical methods and recommendations for their application. Am. J. Hum. Genet., 86, 6-22.
6. Yu,K. et al. (2009) Pathway analysis by adaptive combination of P-values. Genet. Epidemiol., 33, 700-709.
7. Ruczinski,I. et al. (2003) Logic regression. J. Comput. Graph. Stat., 12, 475-511.
8. Kooperberg,C. et al. (2005) Identifying interacting SNPs using Monte Carlo logic regression. Genet. Epidemiol., 28, 157-170.
9. Duell,E.J. et al. (2002) A population-based study of the Arg399Gln polymorphism in X-ray repair cross- complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma. Cancer Res., 62, 4630-4636.
10. Jiao,L. et al. (2007) The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk. Cancer Lett., 245, 61-68.
11. McWilliams,R.R. et al. (2009) Nucleotide excision repair pathway polymorphisms and pancreatic cancer risk: evidence for role of MMS19L. Cancer Epidemiol. Biomarkers Prev., 18, 1295-1302.
12. Huxley,R. et al. (2005) Type-II diabetes and pancreatic cancer: a metaanalysis of 36 studies. Br. J. Cancer, 92, 2076-2083.
13. Stolzenberg-Solomon,R.Z. et al. (2005) Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA, 294, 2872-2878.
14. Jee,S.H. et al. (2005) Fasting serum glucose level and cancer risk in Korean men and women. JAMA, 293, 194-202.
15. Gapstur,S.M. et al. (2000) Abnormal glucose metabolism and pancreatic cancer mortality. JAMA, 283, 2552-2558.
16. Lowenfels,A.B. et al. (1999) Chronic pancreatitis and other risk factors for pancreatic cancer. Gastroenterol. Clin. North Am., 28, 673-685.
17. Olson,S.H. (2012) Selected medical conditions and risk of pancreatic cancer. Mol. Carcinog., 51, 75-97.
18. Loza,M.J. et al. (2007) Assembly of inflammation-related genes for pathway-focused genetic analysis. PLoS One, 2, e1035.
19. Zaret,K.S. (2008) Genetic programming of liver and pancreas progenitors: lessons for stem-cell differentiation. Nat. Rev. Genet., 9, 329-340.
20. Zaret,K.S. et al. (2008) Generation and regeneration of cells of the liver and pancreas. Science, 322, 1490-1494.
21. Shih,D.Q. et al. (2001) Loss of HNF-1alpha function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism. Diabetes, 50, 2472-2480.
22. Fayard,E. et al. (2004) LRH-1: an orphan nuclear receptor involved in development, metabolism and steroidogenesis. Trends Cell Biol., 14, 250-260.
23. Maestro,M.A. et al. (2007) Distinct roles of HNF1beta, HNF1alpha, and HNF4alpha in regulating pancreas development, beta-cell function and growth. Endocr. Dev., 12, 33-45.
24. Martin,M. et al. (2007) Transcription factors in pancreatic development. Animal models. Endocr. Dev., 12, 24-32.
25. Kaneto,H. et al. (2008) PDX-1 functions as a master factor in the pancreas. Front Biosci., 13, 6406-6420.
26. Annicotte,J.S. et al. (2003) Pancreatic-duodenal homeobox 1 regulates expression of liver receptor homolog 1 during pancreas development. Mol. Cell. Biol, 23, 6713-6724.
27. Pierce,B.L. et al. (2011) Genome-wide "pleiotropy scan" identifies HNF1A region as a novel pancreatic cancer susceptibility locus. Cancer Res., 71, 4352-4358.
28. Haumaitre,C. et al. (2005) Lack of TCF2/vHNF1 in mice leads to pancreas agenesis. Proc. Natl Acad. Sci. USA, 102, 1490-1495.
29. Morris,J.P. et al. (2010) KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma. Nat. Rev. Cancer, 10, 683-695.
30. Glucksmann,M.A. et al. (1997) Novel mutations and a mutational hotspot in the MODY3 gene. Diabetes, 46, 1081-1086.
31. Carette,C. et al. (2007) Exonic duplication of the hepatocyte nuclear factor-1beta gene (transcription factor 2, hepatic) as a cause of maturity onset diabetes of the young type 5. J. Clin. Endocrinol. Metab., 92, 2844-2847.
32. Voight,B.F. et al. (2010) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat. Genet., 42, 579-589.
33. Furuta,H. et al. (2002) Nonsense and missense mutations in the human hepatocyte nuclear factor-1 beta gene (TCF2) and their relation to type 2 diabetes in Japanese. J. Clin. Endocrinol. Metab., 87, 3859-3863.
34. Holmkvist,J. et al. (2006) Common variants in HNF-1 alpha and risk of type 2 diabetes. Diabetologia, 49, 2882-2891.
35. Speliotes,E.K. et al. (2010) Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat. Genet., 42, 937-948.
36. Lee,J.M. et al. (2011) A nuclear-receptor-dependent phosphatidylcholine pathway with antidiabetic effects,. Nature, 474, 506-510.
37. D'Angelo,A. et al. (2010) Hepatocyte nuclear factor 1alpha and beta control terminal differentiation and cell fate commitment in the gut epithelium. Development, 137, 1573-1582.
38. Lussier,C.R. et al. (2010) Loss of hepatocyte-nuclear-factor-1alpha impacts on adult mouse intestinal epithelial cell growth and cell lineages differentiation. PLoS One, 5, e12378.
39. Laurent-Puig,P. et al. (2003) Frequent mutations of hepatocyte nuclear factor 1 in colorectal cancer with microsatellite instability. Gastroenterology, 124, 1311-1314.
40. Rebouissou,S. et al. (2004) Mutation of TCF1 encoding hepatocyte nuclear factor 1alpha in gynecological cancer. Oncogene, 23, 7588-7592.
41. Bluteau,O. et al. (2002) Bi-allelic inactivation of TCF1 in hepatic adenomas. Nat. Genet., 32, 312-315.
42. Pelletier,L. et al. (2010) Loss of hepatocyte nuclear factor 1alpha function in human hepatocellular adenomas leads to aberrant activation of signaling pathways involved in tumorigenesis. Hepatology, 51, 557-566.
43. Lauc,G. et al. (2010) Genomics meets glycomics-the first GWAS study of human N-Glycome identifies HNF1alpha as a master regulator of plasma protein fucosylation. PLoS Genet., 6, e1001256.
44. Kleber,M.E. et al. (2010) Effect of the rs2259816 polymorphism in the HNF1A gene on circulating levels of c-reactive protein and coronary artery disease (the ludwigshafen risk and cardiovascular health study). BMC Med. Genet., 11, 157.
45. Ley,S.H. et al. (2010) Assessing the association of the HNF1A G319S variant with C-reactive protein in Aboriginal Canadians: a populationbased epidemiological study. Cardiovasc. Diabetol., 9, 39.
46. Swann,J.B. et al. (2007) Immune surveillance of tumors. J. Clin. Invest., 117, 1137-1146.
47. Jones,S. et al. (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science, 321, 1801-1806.
48. Goggins,M. et al. (1998) Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas. Cancer Res., 58, 5329-5332.
49. Bonecchi,R. et al. (2011) Chemokines and cancer: a fatal attraction. Cancer Cell, 19, 434-435.
50. Sabio,G. et al. (2010) cJun NH2-terminal kinase 1 (JNK1): roles in metabolic regulation of insulin resistance. Trends Biochem. Sci., 35, 490-496.